Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
G Ital Dermatol Venereol ; 149(2): 161-6, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24819635

ABSTRACT

AIM: Accuracy in melanoma detection is important to recognize early curable melanomas and to minimize the unnecessary excision of benign lesions. The aim of this paper was to evaluate melanoma screening accuracy of Italian pigmented lesion clinics in terms of number needed to excise (NNE), melanoma thickness, and number of melanomas diagnosed during patient follow-up. METHODS: Information on all skin tumors excised in 2011 were extracted from the databases of the participating centers. Information whether the lesion was excised at the baseline examination or during patient follow-up was recorded, as well as the overall number of patients examined in each center in 2011. RESULTS: After e-mail solicitation, 22 of 40 centers agreed to participate. A total of 8229 excised lesions were collected. The overall number of examined patients was 86.564, thus 9.5% of screened patients had a lesion removed. Of the excised lesions, 866 were diagnosed as melanoma (1% of examined patients) and 5311 (88.9%) were melanocytic nevi. Three NNE were calculated giving values of 7.9 excised lesions to find 1 melanoma, 7.1 melanocytic lesions to find 1 melanoma, and 3.7 lesions to find 1 skin malignancy. The median melanoma thickness was 0.6 mm, with only 15.1% of melanomas ≥ 1 mm of thickness. Melanomas detected over time were 96 (11.1%; mean thickness, 0.3 mm), with 15.6% of lesions excised after short-term follow-up and 84.4% after long-term follow-up. CONCLUSION: The NNE values comparable to those achieved in specialized clinical settings and the high number of early melanomas diagnosed at the baseline examination or during patient follow-up indicate a high level of accuracy in melanoma screening achieved by Italian pigmented lesion clinics.


Subject(s)
Ambulatory Care Facilities/statistics & numerical data , Dermatology/organization & administration , Melanoma/diagnosis , Nevus, Pigmented/diagnosis , Skin Neoplasms/diagnosis , Adolescent , Adult , Aged , Carcinoma, Basal Cell/diagnosis , Carcinoma, Basal Cell/epidemiology , Carcinoma, Basal Cell/surgery , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/epidemiology , Carcinoma, Squamous Cell/surgery , Dermoscopy , Early Detection of Cancer , Female , Follow-Up Studies , Humans , Italy/epidemiology , Keratosis, Seborrheic/diagnosis , Keratosis, Seborrheic/epidemiology , Keratosis, Seborrheic/surgery , Male , Melanoma/epidemiology , Melanoma/pathology , Melanoma/surgery , Middle Aged , Neoplasm Grading , Nevus, Pigmented/epidemiology , Nevus, Pigmented/pathology , Nevus, Pigmented/surgery , Skin Neoplasms/epidemiology , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Young Adult
2.
Int J Dermatol ; 30(4): 288-90, 1991 Apr.
Article in English | MEDLINE | ID: mdl-2050460

ABSTRACT

The effects of prednisone, oral acyclovir, and radiotherapy were compared with placebo in the prevention of post-herpetic neuralgia. No treatment used was able to prevent, with statistical significance, post-herpetic neuralgia, although prednisone and acyclovir showed some pain reduction in the acute phase. Radiotherapy was of no value in either the acute or post-herpetic phase.


Subject(s)
Acyclovir/therapeutic use , Herpes Zoster/complications , Neuralgia/prevention & control , Prednisone/therapeutic use , Acute Disease , Acyclovir/administration & dosage , Administration, Oral , Aged , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Neuralgia/drug therapy , Neuralgia/radiotherapy , Prednisone/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...